GABLOFEN Drug Patent Profile
✉ Email this page to a colleague
When do Gablofen patents expire, and when can generic versions of Gablofen launch?
Gablofen is a drug marketed by Piramal Critical and is included in one NDA.
The generic ingredient in GABLOFEN is baclofen. There are twenty-one drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the baclofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gablofen
A generic version of GABLOFEN was approved as baclofen by IVAX SUB TEVA PHARMS on July 21st, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GABLOFEN?
- What are the global sales for GABLOFEN?
- What is Average Wholesale Price for GABLOFEN?
Summary for GABLOFEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 150 |
| Clinical Trials: | 4 |
| Patent Applications: | 5,134 |
| Drug Prices: | Drug price information for GABLOFEN |
| What excipients (inactive ingredients) are in GABLOFEN? | GABLOFEN excipients list |
| DailyMed Link: | GABLOFEN at DailyMed |
Recent Clinical Trials for GABLOFEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | N/A |
| Pennsylvania Department of Health | Phase 2 |
| University of Pennsylvania | Phase 2 |
Pharmacology for GABLOFEN
| Drug Class | gamma-Aminobutyric Acid-ergic Agonist |
| Mechanism of Action | GABA A Agonists GABA B Agonists |
US Patents and Regulatory Information for GABLOFEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Piramal Critical | GABLOFEN | baclofen | INJECTABLE;INTRATHECAL | 022462-001 | Nov 19, 2010 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Piramal Critical | GABLOFEN | baclofen | INJECTABLE;INTRATHECAL | 022462-003 | Nov 19, 2010 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Piramal Critical | GABLOFEN | baclofen | INJECTABLE;INTRATHECAL | 022462-002 | Nov 19, 2010 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Piramal Critical | GABLOFEN | baclofen | INJECTABLE;INTRATHECAL | 022462-004 | Jun 22, 2012 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
